Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ball

Showing results (901-910 of 1,006) with videos related to

Pageof 101
Sort By:
Surgery|January 2, 2021
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula developmentFabio Casciani, Maxwell T Trudeau, Horacio J Asbun, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitorsJoshua Close, Richard Heidebrecht, John Hendrix, et al.
JAMA Surgery|May 30, 2019
Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary CarcinomaBrett L Ecker, Charles M Vollmer, Stephen W Behrman, et al.
World Journal of Emergency Surgery : WJES|April 12, 2018
Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteriaMatti Tolonen, Federico Coccolini, Luca Ansaloni, et al.
Chemmedchem|February 7, 2012
Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting propertiesPaul J Coleman, John D Schreier, Christopher D Cox, et al.
Annals of Surgery|January 5, 2016
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance EvaluationMatthew T McMillan, Sameer Soi, Horacio J Asbun, et al.
Surgery|August 26, 2021
A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be betterLisa S Brubaker, Fabio Casciani, William E Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
The Journal of Trauma and Acute Care Surgery|December 19, 2017
Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma studyEric J Ley, Samuel D Leonard, Galinos Barmparas, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Pageof 101

Showing results (901-910 of 1,006) with videos related to

Sort By:
Pageof 101
Surgery|January 2, 2021
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula developmentFabio Casciani, Maxwell T Trudeau, Horacio J Asbun, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitorsJoshua Close, Richard Heidebrecht, John Hendrix, et al.
JAMA Surgery|May 30, 2019
Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary CarcinomaBrett L Ecker, Charles M Vollmer, Stephen W Behrman, et al.
World Journal of Emergency Surgery : WJES|April 12, 2018
Getting the invite list right: a discussion of sepsis severity scoring systems in severe complicated intra-abdominal sepsis and randomized trial inclusion criteriaMatti Tolonen, Federico Coccolini, Luca Ansaloni, et al.
Chemmedchem|February 7, 2012
Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting propertiesPaul J Coleman, John D Schreier, Christopher D Cox, et al.
Annals of Surgery|January 5, 2016
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance EvaluationMatthew T McMillan, Sameer Soi, Horacio J Asbun, et al.
Surgery|August 26, 2021
A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be betterLisa S Brubaker, Fabio Casciani, William E Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
The Journal of Trauma and Acute Care Surgery|December 19, 2017
Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma studyEric J Ley, Samuel D Leonard, Galinos Barmparas, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Pageof 101